Disease/Infection News

RSS

BiondVax gains additional support from NATI for ongoing development of Universal Flu Vaccine

BiondVax Pharmaceuticals Ltd. announced today that the National Authority for Technological Innovation, formerly known as the Office of the Chief Scientist, agreed to fund up to 40% of a NIS 3.6 million (US$920,000) project towards ongoing development of the Company's Universal Flu Vaccine.

18 Feb 2016

Specialised white blood cell in birds can destroy fatal fungal infection

Scientists have discovered that a specialised white blood cell found in birds can destroy a potentially fatal fungal infection which affects more than one million people every year.

18 Feb 2016

Patients with chronic kidney disease and periodontitis have higher mortality rate

New findings from the University of Birmingham show that patients with chronic kidney disease patients and periodontitis (severe gum disease) have a higher mortality rate than those with chronic kidney disease alone.

18 Feb 2016

New treatment protects mice from MERS infection

In a new study, University of Maryland School of Medicine researchers have had promising results with a new treatment for Middle East Respiratory Syndrome (MERS). The study, published today in the journal Science Translational Medicine, found a new treatment that protected mice from MERS infection.

18 Feb 2016

Virginia Tech experts explore new strategy to eradicate harmful viruses

With the outbreak of viruses like Zika, chikungunya, and dengue on the rise, public health officials are desperate to stop transmission.

18 Feb 2016

Discovery could lead to more effective vaccines, personalised therapies for TB

Tuberculosis (TB) used to kill one in seven people around the world before the advent of antibiotics. However the increasing prevalence of multi-drug resistant TB means that doctors are running out of options in trying to combat this bacterium.

18 Feb 2016

FDA issues new guidance to reduce risk of Zika blood transmission

As a safety measure against the emerging Zika virus outbreak, today the U.S. Food and Drug Administration issued a new guidance recommending the deferral of individuals from donating blood if they have been to areas with active Zika virus transmission, potentially have been exposed to the virus, or have had a confirmed Zika virus infection.

18 Feb 2016

Early life factors contribute to aging of lungs

Smoking mothers, respiratory infections and the date you were born contribute to determine how fast your lungs are aging.

17 Feb 2016

Small chemical change to existing antibacterial drug may result in better treatment for TB

Researchers with Vanderbilt University have discovered that one small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis.

17 Feb 2016

WRAIR begins Phase 1 clinical trial to evaluate MERS vaccine candidate

The Walter Reed Army Institute of Research began vaccinations today in a Phase 1 clinical trial to evaluate the safety and immune response of a vaccine candidate to prevent Middle East Respiratory Syndrome (MERS).

17 Feb 2016

Atlas io system allows infectious diseases to be detected in less than 30 minutes

University of Bath spin-out biotechnology company Atlas Genetics has won approval from the EU to sell a device that detects the sexually transmitted disease chlamydia.

17 Feb 2016

New vaccination campaign projected to decrease HFMD incidence in China

Broad vaccination with newly available monovalent hand, foot, and mouth disease (HFMD) vaccines will decrease HFMD incidence in China, according to predictions from an epidemiologic model published this week in PLOS Medicine.

17 Feb 2016

Researchers one step closer to developing new treatment strategy to combat TB

By uncovering the 3-dimensional structure of an enzyme that is critical for the survival of the bacterium that cause tuberculosis, researchers may be one step closer to developing a new strategy to combat TB infections.

17 Feb 2016

Bacteria lurking in dental water lines

Bacteria lurking in the water lines at the dentist's office are tougher than we thought, according to a new paper published in Water Research. The study reveals that the disinfectants recommended by companies that manufacture the water lines don't actually shift all the bacteria in the lines, which means they're never completely clean.

17 Feb 2016

New staging system proposed to identify most appropriate treatments for HPV-related OPC

Human papillomavirus (HPV) status is a strong predictor of prognosis for patients with oropharyngeal carcinoma (OPC), but the current staging system does not adequately account for biological and clinical differences between HPV-positive OPC and HPV-negative OPC, commonly caused by alcohol and tobacco use.

17 Feb 2016

Experts available to discuss use of meningitis vaccine in childhood immunization programs

Global vaccine experts and officials from all 26 African "meningitis belt" countries will convene in Ethiopia next week in advance of the Ministerial Conference on Immunization to celebrate one of Africa's biggest public health achievements--the introduction of a vaccine that in five years of use has protected more than 235 million people in 16 countries, nearly eliminating meningitis A disease on the continent.

17 Feb 2016

Zika virus isn't stopping Americans from making international travel plans, study finds

Global concerns about Zika virus aren't stopping Americans from making international travel plans, a new study finds, but many who do plan to go abroad say they want more information about the virus.

17 Feb 2016

New UNC School of Medicine study shows how some bacteria can spread throughout the body

Bacteria have evolved thousands of clever tactics for invading our bodies while evading our natural defenses. Now, UNC School of Medicine scientists studying one of the world's most virulent pathogens and a separate very common bacterium have discovered a new way that some bacteria can spread rapidly throughout the body - by hitchhiking on our own immune cells.

16 Feb 2016

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).

16 Feb 2016

Anti-biofilm compounds show promise against drug-resistant bacteria associated with hospital-acquired infections

Researchers at the University of Michigan Life Sciences Institute and School of Public Health have discovered a new class of anti-biofilm compounds derived from marine microorganisms that show promise against a drug-resistant bacterium commonly associated with hospital-acquired infections.

16 Feb 2016

Disease/Infection News

BiondVax gains additional support from NATI for ongoing development of Universal Flu Vaccine

Specialised white blood cell in birds can destroy fatal fungal infection

Patients with chronic kidney disease and periodontitis have higher mortality rate

New treatment protects mice from MERS infection

Virginia Tech experts explore new strategy to eradicate harmful viruses

Discovery could lead to more effective vaccines, personalised therapies for TB

FDA issues new guidance to reduce risk of Zika blood transmission

Early life factors contribute to aging of lungs

Small chemical change to existing antibacterial drug may result in better treatment for TB

WRAIR begins Phase 1 clinical trial to evaluate MERS vaccine candidate

Atlas io system allows infectious diseases to be detected in less than 30 minutes

New vaccination campaign projected to decrease HFMD incidence in China

Researchers one step closer to developing new treatment strategy to combat TB

Bacteria lurking in dental water lines

New staging system proposed to identify most appropriate treatments for HPV-related OPC

Experts available to discuss use of meningitis vaccine in childhood immunization programs

Zika virus isn't stopping Americans from making international travel plans, study finds

New UNC School of Medicine study shows how some bacteria can spread throughout the body

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Anti-biofilm compounds show promise against drug-resistant bacteria associated with hospital-acquired infections

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News